FOXD3 and breast cancer: FOXD3-AS1, for example, affects the development of breast cancer, nasopharyngeal carcinoma, colon adenocarcinoma, and hepatocellular carcinoma via competing for the endogenous RNAs (ceRNAs) mechanism [15–17].